Physician profile
Matthew Augustin Romano
NPI 1346350402
$177,161.50
in general payments reported to CMS, 2019-2025
13 companies · $47K in 2025
The $47K reported for 2025 was more than what 97% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $8,777 · 2021: $15K · 2022: $22K · 2023: $13K · 2024: $43K · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $78K · Travel and Lodging: $18K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,700 · Food and Beverage: $3,510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $78,275.00 |
| Travel and Lodging | $17,729.55 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,700.00 |
| Food and Beverage | $3,510.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $107,896.75 | 2020-2025 | Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve, Konect Resilia |
| Atricure, INC. | $20,422.09 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Abbvie INC. | $12,270.83 | 2022-2023 | Botox |
| Medtronic, INC. | $11,896.34 | 2021-2025 | Simulus, Apollotm |
| Medtronic Vascular, INC. | $9,513.91 | 2019-2020 | |
| Allergan, INC. | $5,621.03 | 2019-2021 | |
| Intuitive Surgical, INC. | $5,149.06 | 2019-2020 | |
| Abbott Laboratories | $2,865.12 | 2019-2025 | Mitraclip, Triclip, Freestyle Libre 3 |
| Stryker Corporation | $1,200.00 | 2021-2023 | Sonopet Iq |
| Pulse Biosciences, INC. | $167.81 | 2025 | Cellfx |
| Baxter Healthcare | $91.38 | 2022-2024 | Preveleak |
| Boston Scientific Corporation | $67.18 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Romano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.